Electrophysiologic effects and efficacy of intravenous propafenone in terminating atrioventricular reentrant tachycardia in children
In pediatric patients with atrioventricular reentrant tachycardia, intravenous propafenone exhibits its electrophysiologic effects in a dose-dependent manner by slowing or blocking retrograde conduction at the accessory connection. The high drug efficacy (81%) in terminating tachycardia is not dependent on patient age or retrograde conduction properties of the accessory connection.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2001 |
|---|---|
| Erschienen: |
2001 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:87 |
|---|---|
| Enthalten in: |
The American journal of cardiology - 87(2001), 6 vom: 15. März, Seite 802-4, A9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hessling, G [VerfasserIn] |
|---|
| Themen: |
68IQX3T69U |
|---|
| Anmerkungen: |
Date Completed 05.04.2001 Date Revised 22.06.2019 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM111606659 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM111606659 | ||
| 003 | DE-627 | ||
| 005 | 20231222155951.0 | ||
| 007 | tu | ||
| 008 | 231222s2001 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0372.xml |
| 035 | |a (DE-627)NLM111606659 | ||
| 035 | |a (NLM)11249911 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hessling, G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Electrophysiologic effects and efficacy of intravenous propafenone in terminating atrioventricular reentrant tachycardia in children |
| 264 | 1 | |c 2001 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 05.04.2001 | ||
| 500 | |a Date Revised 22.06.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a In pediatric patients with atrioventricular reentrant tachycardia, intravenous propafenone exhibits its electrophysiologic effects in a dose-dependent manner by slowing or blocking retrograde conduction at the accessory connection. The high drug efficacy (81%) in terminating tachycardia is not dependent on patient age or retrograde conduction properties of the accessory connection | ||
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Anti-Arrhythmia Agents |2 NLM | |
| 650 | 7 | |a Propafenone |2 NLM | |
| 650 | 7 | |a 68IQX3T69U |2 NLM | |
| 700 | 1 | |a Brockmeier, K |e verfasserin |4 aut | |
| 700 | 1 | |a Ruediger, H J |e verfasserin |4 aut | |
| 700 | 1 | |a Ulmer, H E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The American journal of cardiology |d 1958 |g 87(2001), 6 vom: 15. März, Seite 802-4, A9 |w (DE-627)NLM000025364 |x 1879-1913 |7 nnns |
| 773 | 1 | 8 | |g volume:87 |g year:2001 |g number:6 |g day:15 |g month:03 |g pages:802-4, A9 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 87 |j 2001 |e 6 |b 15 |c 03 |h 802-4, A9 | ||